Healthcare leader with over 25 years of experience in the pharmaceutical industry, combining expertise in market access, health economics, and clinical research. Proven ability to drive reimbursement strategies, lead cross-functional teams, and build strong partnerships with health authorities, payers, and patient advocacy groups.

Held leadership roles as Medical Director (Pfizer and AstraZeneca) and Market Access Director (BMS, Swixx Biopharma), combining scientific, regulatory, and access expertise to deliver sustainable business and patient outcomes.  

In the early career, clinical trials and medical affairs provided a solid scientific foundation — coordinating investigator sites, ensuring GCP compliance, and translating clinical data into real-world evidence for access decisions. 

Actual position: Health & Value Lead Pfizer Leader of Clinical Trials Group and member in Strategic Council of Innovation Hub for Health